Suchergebnisse - "Riecke, Armin"

PubPharm (40)

1

The addition of chloroquine and bevacizumab to standard radiochemotherapy for recurrent glioblastoma multiforme

enthalten in: British journal of neurosurgery | 2024

von Witte, H. | Riecke, A. | Steinestel, K. | +5

2

Late Onset of Primary Hemophagocytic Lymphohistiocytosis (HLH) with a Novel Constellation of Compound Heterozygosity Involving Two Missense Variants in the PRF1 Gene

enthalten in: International journal of molecular sciences | 2024

von Stadermann, A. | Haar, M. | Riecke, A. | +11

3

Spindle cell oncocytoma of the neurohypophysis with metastasis to the sphenoparietal sinus and immunohistochemical negativity for S100 and epithelial membrane antigen (EMA)

enthalten in: British journal of neurosurgery | 2023

von Witte, H. | Riecke, A. | Saeger, W. | +4

4

Multifocal and hormone-dependent epithelioid hemangioendothelioma with osteolysis of the second cervical vertebral body : report of an unprecedented surgical approach by using autologous bone graft

enthalten in: British journal of neurosurgery | 2023

von Witte, H. | Riecke, A. | Mayer, T. | +7

5

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition

enthalten in: Journal of cancer research and clinical oncology | 2023

von Bauer, A. | Gebauer, N. | Knief, J. | +5

6

The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic (GEP-NEN) System

enthalten in: Cancers | 2022

von Gebauer, N. | Ziehm, M. | Gebauer, J. | +7

7

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7) : part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2022

von Goldschmidt, H. | Mai, E. | Bertsch, U. | +123

CommentIn: Lancet Haematol. 2022 Nov;9(11):e798-e799. - PMID 36328036

8

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition

enthalten in: Journal of cancer research and clinical oncology | 2022

von Bauer, A. | Gebauer, N. | Knief, J. | +5

9

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition

enthalten in: Journal of cancer research and clinical oncology | 2022

von Bauer, A. | Gebauer, N. | Knief, J. | +5

10

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition

enthalten in: Journal of cancer research and clinical oncology | 2022

von Bauer, A. | Gebauer, N. | Knief, J. | +5